Literature DB >> 16925698

Rapid and cost-effective method to assess vision disorders in a population.

Andreas Müller1, Hien T Vu, John G Ferraro, Jill E Keeffe, Hugh R Taylor.   

Abstract

PURPOSE: The aim was to develop a means of rapidly assessing eye health in a cost- and time-effective way to monitor changes over time.
METHODS: Key features of the five main eye diseases that cause vision loss in Australia were assessed. Participation was volunteer-based from randomly selected Melbourne suburbs. Recruitment was by mail. Anterior segments and fundi were photographed with a digital non-mydriatic fundus camera. Visual fields were tested with Frequency Doubling Technology. A questionnaire collected information about demographics, general health and lifestyle. Findings from this rapid assessment were compared with those from a population-based study.
RESULTS: A total of 1695 people, aged between 70 and 79 years (mean 74), were recruited. The rates and causes of visual impairment were similar between the rapid assessment method and the population-based study. Among the 134 people (8%) with visual impairment at presentation, 98 (73%) had undercorrected refractive error, 17 (13%) had age-related macular degeneration, 11 (8%) had cataract, 2 (2%) had diabetic retinopathy and 2 (2%) had glaucoma. Screening costs per participant were only about AU$145, compared with AU$433 in the Melbourne Visual Impairment Project (VIP). The application of Frequency Doubling Technology as well as the use of a non-mydriatic digital camera for fundus and lens photography resulted in an average examination time of less than half the time needed in the VIP. Data collection took 3 months rather than 4 years in the VIP.
CONCLUSION: The rapid assessment method was efficient in time and cost and produced results comparable to a normal population-based survey. Repeating the study design for a similarly sampled group every 2 years would allow the assessment of changes in the prevalence of undiagnosed eye disease.

Entities:  

Mesh:

Year:  2006        PMID: 16925698     DOI: 10.1111/j.1442-9071.2006.01275.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

1.  Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.

Authors:  Liubov Robman; Robyn Guymer; Robyn Woods; Stephanie Ward; Rory Wolfe; James Phung; Lauren Hodgson; Galina Makeyeva; Khin Zaw Aung; Tom Gilbert; Jessica Lockery; Y-Anh Le-Pham; Suzanne Orchard; Elsdon Storey; Walter Abhayaratna; Daniel Reid; Michael E Ernst; Mark Nelson; Christopher Reid; John McNeil
Journal:  Contemp Clin Trials Commun       Date:  2017-03-27

2.  Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing.

Authors:  Kate M Learmonth; Dale A McPhee; Darren K Jardine; Sandy K Walker; Thein-Thein Aye; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

3.  Cost-effectiveness and diagnostic accuracy of telemedicine in macular disease and diabetic retinopathy: A systematic review and meta-analysis.

Authors:  Waqas Ullah; Sana Khan Pathan; Ankur Panchal; Swapna Anandan; Kaiser Saleem; Yasar Sattar; Ejaz Ahmad; Maryam Mukhtar; Haq Nawaz
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.